Theseus Pharmaceuticals I... (THRX)
NASDAQ: THRX
· Real-Time Price · USD
4.07
0.01 (0.25%)
At close: Feb 13, 2024, 9:59 PM
Theseus Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 46.89M | 47.47M | 109.7M | 94.61M | 115.56M | 135.09M | 146.28M | 244.66M | 90.4M | 97.59M |
Short-Term Investments | 158.23M | 160.74M | 126.94M | 103.37M | 96.87M | 89.7M | 85.76M | n/a | n/a | n/a |
Long-Term Investments | 20.31M | 26.03M | 6.98M | 13.82M | 8.54M | 3.81M | 4.95M | n/a | n/a | n/a |
Other Long-Term Assets | 399K | 794K | 7.4M | 5.9M | 1.86M | 1.99M | 2.85M | 2.95M | 6.13M | 2.75M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.46M | 5.55M | 5.76M | 4.14M | 2.56M | 2.72M | 2.91M | 3.31M | 1.08M | 1.74M |
Total Current Assets | 209.59M | 213.75M | 236.63M | 197.98M | 215M | 227.52M | 234.95M | 247.97M | 91.49M | 99.33M |
Property-Plant & Equipment | 4.33M | 4.5M | 4.61M | 4.75M | 4.89M | 4.98M | 4.76M | 11K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 25.04M | 31.32M | 18.99M | 24.47M | 15.3M | 10.77M | 12.55M | 2.96M | 6.13M | 2.75M |
Total Assets | 234.63M | 245.07M | 255.62M | 222.45M | 230.29M | 238.29M | 247.5M | 250.93M | 97.62M | 102.07M |
Account Payables | 1.31M | 2.42M | 2.19M | 4.97M | 1.82M | 1.5M | 1.43M | 1M | 2.39M | 1.77M |
Deferred Revenue | 4.58M | 4.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 759K | 754K | 748K | 743K | 779K | 774K | 1.18M | n/a | n/a | n/a |
Other Current Liabilities | 349K | 4.51M | 3.69M | 5.41M | 5.21M | 2.93M | 2.78M | 2.68M | 3.29M | 2.2M |
Total Current Liabilities | 7M | 7.68M | 6.62M | 11.13M | 7.81M | 5.21M | 5.38M | 3.68M | 5.68M | 3.97M |
Long-Term Debt | 2.9M | 3.01M | 3.13M | 3.24M | 3.34M | 3.44M | 3.54M | n/a | n/a | n/a |
Other Long-Term Liabilities | 205K | 292K | 379K | 466K | 553K | 641K | 728K | 815K | 142.08M | 142.17M |
Total Long-Term Liabilities | 3.1M | 3.31M | 3.51M | 3.7M | 3.89M | 4.08M | 4.27M | 815K | 142.08M | 142.17M |
Total Liabilities | 10.11M | 10.99M | 10.13M | 14.83M | 11.7M | 9.29M | 9.65M | 4.5M | 147.76M | 146.14M |
Total Debt | 3.66M | 3.77M | 3.88M | 3.98M | 4.12M | 4.22M | 4.72M | n/a | n/a | n/a |
Common Stock | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | n/a | n/a |
Retained Earnings | -155.08M | -141.58M | -126.77M | -112.19M | -98.47M | -83.72M | -72.08M | -61.58M | -52.92M | -45.55M |
Comprehensive Income | -345K | -561K | -159K | -386K | -550K | -332K | -129K | n/a | n/a | n/a |
Shareholders Equity | 224.52M | 234.08M | 245.49M | 207.62M | 218.59M | 229M | 237.85M | 246.43M | -50.15M | -44.07M |
Total Investments | 178.54M | 186.77M | 133.91M | 117.19M | 105.41M | 93.51M | 90.7M | n/a | n/a | n/a |